ArticleBlood2017

Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies.

Changchun Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.